The Miami Cancer Institute at Baptist Health South Florida entered into a multiyear agreement with healthcare analytics startup Cota, the company confirmed Jan. 3.
Physicians at the Miami Cancer Institute will have access to the startup's Cota Nodal Address system, which categorizes clinical and genomic data based on demographics, diseases and intended therapies for similar patients.
Miami Cancer Institute officials hope the product will help clinicians inform and personalize cancer care.
"With the ability to see genomic-level data alongside cost and historical clinical data, Cota will help accelerate our journey to value-based care," said Leonard Kalman, MD, executive deputy director and CMO of Miami Cancer Institute.